Localization of vitronectin in the normal and atherosclerotic human vessel wall

Histochemistry and Cell Biology

Volumn 107, Issue 4, 1997, Pages 313-320

  Van Aken, Benien E ^a   Seiffert, Dietmar ^a   Thinnes, Theresa ^a   Loskutoff, David J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL;

ARTERIOSCLEROSIS; HUMANS; IN SITU HYBRIDIZATION; MUSCLE, SMOOTH, VASCULAR; RNA, MESSENGER; VITRONECTIN;

EID: 0030908723     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004180050116     Document Type: Article

References (39)

1. 3, for angiogenesis. Science 264:569-571
2. Dahlbaeck K (1993) Vitronectin association with skin. In: Preissner KT, Rosenblatt S, Kost C, Wegerhoff J, Mosher DF (eds) Biology of vitronectins and their receptors. Excerpta Medica, Amsterdam, pp 91-98
3. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L (1985) Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44:139-265
4. Davies MJ (1994) Mechanism of thrombosis in atherosclerosis. In: Colman RW, Hirsh J, Marder VJ, Salzman ED (eds) Hemostasis and thrombosis. Lippincott, Philadelphia, pp 1224-1237
5. Declerck PJ, Mol M de, Alessi M-C, Baudner S, Paques E-P, Preissner KT, Müller-Berghaus G, Collen D (1988) Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma: identification as a multimeric form of S protein (vitronectin). J Biol Chem 263:15454-15461
6. Ehrlich HJ, Klein Gebbink R, Keijer J, Linders M, Preissner KT, Pannekoek H (1990) Alteration of serpin specificity by a protein cofactor: vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties. J Biol Chem 265:13029-13035
7. Falk RJ, Podack E, Dalmasso A, Jenette JC (1987) Localization of S-protein and its relationship to the membrane attack complex of complement in renal tissues. Am J Pathol 127:182-190
8. Garvey W, Fathi A, Bigelow F, Carpenter B, Jimenez C (1987) A combined elastic, fibrin and collagen stain. Stain Technol 62:365-367
9. Gebb C, Hayman EG, Engvall E, Ruoslahti E (1986) Interaction of vitronectin with collagen. J Biol Chem 261:16698-16703
10. Guettier C, Hinglais N, Bruneval P, Kazatchkine M, Bariety J, Camilleri J-P (1989) Immunohistochemical localization of S protein/vitronectin in human atherosclerotic versus arteriosclerotic arteries. Virchows Arch 414:309-313
11. Hayman EG, Pierschbacher MD, Oehgren Y, Ruoslahti E (1983) Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc Natl Acad Sci USA 80:4003-4007
12. Hetland G, Pettersen HB, Mollnes TE, Johnson E (1989) S protein is synthesized by human monocytes and macrophages in vitro. Scand J Immunol 29:15-21
13. Hintner H, Dahlbaeck K, Dahlbaeck B, Pepys MB, Breathnach SM (1991) Tissue vitronectin in normal adult human dermis is non-covalently bound to elastic tissue. J Invest Dermatol 96:747-753
14. Izumi M, Shimo-Oka T, Morishita N, Il I, Hayashi M (1988) Identification of the collagen-binding domain of vitronectin using monoclonal antibodies. Cell Struct Funct 13:217-225
15. Keeton M, Eguchi Y, Sawdey M, Ahn C, Loskutoff DJ (1993) Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue. Am J Pathol 142:59-70
16. Loskutoff DJ, Sawdey M, Mimuro J (1989) Type 1 plasminogen activator inhibitor. Prog Hemostasis Thromb 9:87-116
17. Lupu F, Bergonzelli GE, Heim DA, Cousin E, Genton CY, Bachmann F, Kruithof EKO (1993) Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler Thromb Vasc Biol 13:1090-1100
18. Niculescu F, Rus HG, Porutiu D, Ghiurca V, Vlaicu R (1989) Immunoelectron-microscopic localization of S-protein/vitronectin in human atherosclerotic wall. Atherosclerosis 78:197-203
19. Preissner KT (1991) Structure and biological role of vitronectin. Annu Rev Cell Biol 7:275-310
20. Preissner KT, Poetzsch B (1995) Vessel wall-dependent metabolic pathways of the adhesive proteins, von-Willebrand factor and vitronectin. Histol Histopathol 10:239-251
21. Preissner KT, Holzhueter S, Justus C, Müller-Berghaus G (1989) Identification and partial characterization of platelet vitronectin: evidence for complex formation with platelet-derived plasminogen activator inhibitor-1. Blood 74:1989-1996
22. Preissner KT, Grulich-Henn J, Ehrlich HJ, Declerck P, Justus C, Collen D, Pannekoek H, Müller-Berghaus G (1990) Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin. J Biol Chem 265:18490-18498
23. Reilly JT, Nash JR (1988) Vitronectin (serum spreading factor): its localization in normal and fibrotic tissue. J Clin Pathol 41:1269-1272
24. Riessen JR, Issner JM, Blessing E, Loushin C, Nikol S, Wight TN (1994) Regional differences in the distribution of proteoglycans biglycan and decorin in the extracullar matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol 144:962-974
25. Robbie LA, Booth NA, Brown PAJ, Bennet B (1996) Inhibitors of fibrinolysis are elevated in atherosclerotic plaque. Arterioscler Thromb Vasc Biol 16:539-545
26. Saksela O, Rifkin DB (1988) Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol 4:93-126
27. Sato R, Komine Y, Imanaka T, Takano T (1990) Monoclonal antibody EMR1a/212D recognizing site of deposition of extracellular lipid in atherosclerosis: isolation and characterization of a cDNA clone for the antigen. J Biol Chem 265:21232-21236
28. Sawa H, Sobel BE, Fujii S (19931 Potentiation by hypercholesterolemia of the induction of aortic intramural synthesis in plasminogen activator inhibitor type 1 by endothelial injury. Circ Res 73:671-680
29. Schneiderman J, Sawdey M, Keeton M, Bordin GM, Bernstein EF, Dilley RB, Loskutoff DJ (1992) Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA 89:6998-7002
30. Seiffert D, Schleef RR (1996) Two functionally distinct pools for vitronectin (Vn) in the blood circulation: identification of a heparin-binding competent population of Vn within platelet alpha-granules. Blood 88:552-560
31. Seiffert D, Wagner NN, Loskutoff DJ (1990) Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor. J Cell Biol 111:1283-1291
32. Seiffert D, Keeton M, Eguchi Y, Sawdey M, Loskutoff DJ (1991) Detection of vitronectin inRNA in tissues and cells of the mouse. Proc Natl Acad Sci USA 88:9402-9406
33. Seiffert D, Crain K, Wagner NV, Loskutoff DJ (1994) Vitronectin gene expression in vivo: evidence for extrahepatic synthesis and acute phase regulation. J Biol Chem 269:19836-19842
34. Seiffert D, Bordin GM, Loskutoft DJ (1996) Evidence that extrahepatic cells express vitronectin mRNA at rates approaching those of hepatocytes. Histochem Cell Biol 105:195-201
35. Shi S-R, Chaiwum B, Young L, Cole RJ, Taylor CR (1993) Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. J Histochem Cytochem 41:1599-1604
36. Stefansson S, Lawrence DA (1996) The serpin PAI-1 inhibits cell migration by blocking integrin alpha v beta 3 binding to vitronectin. Nature 383:441-443
37. Tomasini BR, Mosher DF (1988) Conformational states of vitronectin: preferential expression of an antigenic epitope when vitronectin is covalently and noncovalently complexed with thrornbin-antithrombin III or treated with urea. Blood 72:903-912
38. Tomasini BR, Mosher DF (1990) Vitronectin. In: Coller BS (ed) Progress in hemostasis and thrombosis. Saunders, Philadelphia, pp 269-305
39. Wilcox JN, Smith KM, Schwartz SM, Gordon D (1989) Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 86:2839-2843